Viral radiopharmaceuticals for the treatment/cure of COVID-19 and other viruses

Abstract

In general, the patent herein is a radioactive chemical which attaches to the virus and releases radiation which kills the virus. Specifically, the chemical is an alpha-ketoamide designed to attach to the virus. However, instead of 2 bromine atoms, Iodine-131 is at the location of where the bromine atoms would have been. Iodine-131 is a radioactive element which releases ionizing radiation. The virus with which this radioactive chemical is designed for is the COVID-19 coronavirus, although the patent is for any virus. Since, modifications can be made in chemical structure and radioactive chemical species, the patent is for any and all chemicals which contain any type of radioactive element to kill or disrupt any type of virus.

Claims

1. A method of treating COVID-19 comprising administering the compound ##STR00001##

Description

(1) Disclosure of Invention: The scope of this claim applies to all viruses. The scope of this claim applies to any chemical with any radioactive elements. The scope of this claim applies to any type of radioactive element.

(2) Industrial Applicability: This radioactive chemical can be taken as a pill or injected into the blood to treat or cure viruses including COVID-19.

BRIEF DESCRIPTION OF THE DRAWINGS

(3) FIG. [1]: Chemical Structure of Alpha-Ketoamide with Iodine-131

(4) FIG. [2]: Chemical Formula for Alpha-Ketoamide with Iodine-131